US Stock MarketDetailed Quotes

GYRE Gyre Therapeutics

Watchlist

13.420
+0.810+6.42%

Close Jul 12 16:00 ET

13.010
-0.410-3.06%

Post 17:26 ET

1.15BMarket Cap-13079P/E (TTM)

Gyre Therapeutics Stock Forum

Jaguar8

May 30 15:11

NEWS

$Gyre Therapeutics(GYRE.US)$
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
Gyre Therapeutics (Nasdaq: GYRE), a biotech firm specializing in anti-fibrotic treatments, has received approval from China's NMPA for its Investigational New Drug (IND) application for F230. This drug, a selective endothelin receptor antagonist, is aimed at treating pulmonary arterial hypertension (PAH), a severe and progressive diso...

108S

May 29 08:33

$Gyre Therapeutics(GYRE.US)$Gyre Therapeutics Expects Addition To Russell - moomoo

Moomoo Recap US

Jan 22 15:13

ColumnsWall Street Street | Great Day For Volume Stocks on Fresh Index Records

RECAP
U.S. stocks advanced on Monday, building off a record finish ahead of the ramping up of fourth-quarter earnings season.
The $Dow Jones Industrial Average(.DJI.US)$ rose 138 points, or 0.26%, to 38,000. The $S&P 500 Index(.SPX.US)$ was up 10 points, or 0.22%, at 4,850. The $Nasdaq Composite Index(.IXIC.US)$advanced 49 points, or 0.32%, to 15,360.
While the S&P 500 finally returned to record territory on Friday, skeptic...

Kevin Travers

Jan 22 09:51

ColumnsBiotTech Rises with the Index Tide

After two major indexes reached all-time highs, pharmaceutical stocks for companies in drug trials were caught up in the energy and rocketed forward. The largest gainers were $Spyre Therapeutics(SYRE.US)$, up 26% Monday morning, and $Gyre Therapeutics(GYRE.US)$ +10%.
Spyre felt the positive pressure from fresh buy ratings by analysts like Stifel. $Ginkgo Bioworks(DNA.US)$ also roase 9%, despite a new sell rating from Goldman Sachs.
But monday morning was not al...